"None of the Public Sector Undertakings (PSUs) under the administrative control of Department of Pharmaceuticals are manufacturing drugs needed for cancer treatment," Minister of State for Chemicals and Fertilisers Hansraj Gangaram Ahir said in a written reply to the Lok Sabha.
PSUs under DoP are: Indian Drugs & Pharmaceuticals Ltd, Hindustan Antibiotics Ltd, Rajasthan Drugs & Pharmaceuticals Ltd, Karnataka Antibiotics & Pharmaceuticals Ltd and Bengal Chemicals and Pharmaceuticals Ltd.
In reply to a separate question, Ahir said DoP is framing recruitment rules to fill the vacant technical posts.
On Uniform Code of Pharmaceutical Marketing Practices (UCPMP), Ahir said majority of the companies have favoured making the code mandatory.
"A review on the implementation of of the UCPMP was held wherein it was found that majority of the companies favoured making the UCPMP mandatory," he said.
The government had prepared UCPMP which was to be adopted voluntarily by the pharma companies for a period of six months with effect from January 1, 2015.
The code was later extended up to December 31.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
